Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 25, Issue 8, 2009, Pages 504-507

  Lankarani, Mahnaz ^a   Valizadeh, Neda ^a   Heshmat, Ramin ^a   Peimani, Maryam ^a   Sohrabvand, Farnaz ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

HOMA index; Insulin resistance; Metabolic syndrome; Polycystic ovary syndrome

Indexed keywords

C PEPTIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CASE CONTROL STUDY; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HOMEOSTASIS; HUMAN; INFORMED CONSENT; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; WAIST HIP RATIO;

ADOLESCENT; ADULT; BODY MASS INDEX; CASE-CONTROL STUDIES; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; POLYCYSTIC OVARY SYNDROME; PREVALENCE; PROGNOSIS; WAIST-HIP RATIO; YOUNG ADULT;

EID: 70350635421     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590902972083     Document Type: Review

References (20)

1. Legro RS, Azziz R, Ehrmann D, Fereshetian AG, O'keefe M, Ghazzi MN. Minimal response of circulating lipids in women with polycystic ovary syndrome to improvement in insulin sensitivity with troglitazone. J Clin Endocr Metab 2003; 88:5137-5144.
2. Apridonidze T, Essah PA, Iuorno MJ, Nestler JE. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocr Metab 2005;90: 1929-1935.
3. Leo VD, Marca AL, Petraglia F. Insulin - lowering Agents in the management of polycystic overy syndrome. Endocr Rev 2003;24:633-667.
4. Legro RS, Finegood D, Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocr Metab 1998;83: 2694-2698.
5. Flier JS. Insulin resistance: the metabolic syndrome X. New Engl J Med 1999;341:1402.
6. Fulghesu AM, Angioni S, Portoghese E, Milano F, Batetta B, Paoletti AM, Melis GB. Failures of the homeostatic model assessment calculation score for detecting metabolic deterioration in young patients with polycystic ovary syndrome. Fertil Steril 2006;86:398-404.
7. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine F, Merriam GM, editors. Polycystic ovary syndrome. Boston: Black well scientific; 1992. pp 377-384.
8. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112: 2735.
9. Lergo RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv 2004;59:141-154.
10. Genuth S, Alberti KG, Bennett P. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care 2003;26:3160.
11. Robinson S, HenDerson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG, Franks S. Dyslipidemia is associated with insulin resistance in women polycystic ovaries. Clin Endocrinol 1996;44:277-284. (Pubitemid 26063404)
12. Vrbikova J, Cibula D, Dvorakova K, Stanicka S, Sindelka G, Hill M, Fanta M, Vondra K, Skrha J. Insulin Sensitivity in women with polycystic ovary syndrome. J Clin Endocr Metab 2004;89:2942-2945.
13. Park HR, Choi Y, Lee HJ, Oh JY, Hong YS, Sung YA. The metabolic syndrome in young Korean women with polycystic ovary syndrome. Diabetes Res Clin PR 2007;77S:S243-S246. Available online at www.sciencedirect.com
14. Cussons AJ, Stuckey BGA, watts GF. Metabolic and cardiovascular risk in the polycystic ovary syndrome. Pract Diabetes Int 2005;22:261-265.
15. Kurioka H, Takahashi K, Miyazaki K. Glucose intolerance in japanese patients with polycystic ovary syndrome. Arch Gynecol Obstet 2007;275:169-173.
16. DeUgarte CM, Bartolucci AA, Azziz R. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment. Fertil Steril 2005;83:1454-1460. (Pubitemid 40615820)
17. Kauffman RP, Baker VM, DiMarino P, Gimpel T, castracane VD. Polycystic ovarian syndrome and insulin resistance in white and Mexican American women: a comparison of two distinct populations. Am J Obstet Gynecol 2002;187:1362-1369.
18. Bahrami A. Evaluation of impaired glucose tolerance and type 2 diabetes mellitus prevalence in PCOS and necessity for screening in patients with PCOS. Iran J Diabetes Lipid Disord; Spring Summer 2004;3:141-148.
19. Sheikholeslami H, Mirdamadi M, Ziaee A, Kani C. Insulin resistance in patients with polycystic ovary syndrome. In European congress of endocrinology, 2008 May 3-7; Berlin, Germany: Bioscientifica publishers; Endocrine Abstracts (2008), 16 P648.
20. Cibula D. Is insulin resistance an essential component of PCOS? The influence of confounding factors. Hum Reprod 2004;19:757-759.